“…Several groups revealed that lymphocytes drive initial myeloid cell programming to foster chronic inflammation in a tissue-specific manner. For example, during mammary branching morphogenesis and ductal carcinogenesis, cytokines derived from T H 2-CD4 + T cells, e.g., IL-4 and -13, activate macrophages and monocytes infiltrating mammary tissue (DeNardo et al, 2009; Plaks et al, 2015). In neoplastic scenarios, signaling downstream of IL-4 receptors on monocytes and macrophages triggers protumorigenic T H 2 gene-expression programs that activate tissue-remodeling cascades, via expression and activation of cathepsin proteases, and immune-suppressive programs, via upregulation of IL-10 and immune-checkpoint molecules (DeNardo et al, 2009; Gocheva et al, 2010; Mitchem et al, 2013; Ruffell et al, 2014).…”